Key result
AF in RHD drives significant young morbidity and mortality but lacks specific guidelines and trials.
Why the study?
Current management guidelines based on nonvalvular AF do not apply to rheumatic AF patients, and key aspects of stroke risk, rate control, and nonpharmacological management remain poorly evaluated.
This review highlights the unique clinical profile of rheumatic AF patients and emphasizes the need for tailored management strategies, as current nonvalvular AF guidelines often do not apply.
No takes yet. Share an insight, caveat, or question.
Standard nonvalvular AF guidelines require caution in rheumatic heart disease; leaves open dedicated RCTs in young patients.
Jayaprakash Shenthar (2022) conducted a review in Atrial fibrillation in rheumatic heart disease. Atrial fibrillation in rheumatic heart disease causes significant morbidity and mortality in young patients, yet lacks specific management guidelines and representation in randomized clinical trials.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: